Complement anaphylatoxins in idiopathic mixed cryoglobulinemia. 1985

A Miadonna, and E Leggieri, and A Tedeschi, and M Cottini, and F Invernizzi, and M Froldi, and C Zanussi

Basophil activation, observed in patients with idiopathic mixed cryoglobulinemia, has been related to the complement anaphylatoxins C4a, C3a and C5a. In the present study the plasma levels of the complement anaphylatoxins have been evaluated in 21 patients affected with idiopathic mixed cryoglobulinemia. The plasma concentration of C3a desArg was significantly higher in the patients than in the healthy controls; conversely the plasma values of C4a desArg were significantly lower. C5a desArg was not detectable in plasma from any subject. The high plasma level of C3a desArg in our patients may suggest a role for C3a anaphylatoxin in 'in vivo' basophil activation. No correlation was found between the plasma concentrations of C3a desArg or C4a desArg, the amount of cryoprecipitate and the clinical activity of the disease.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010455 Peptides Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS. Peptide,Polypeptide,Polypeptides
D003176 Complement C3 A glycoprotein that is central in both the classical and the alternative pathway of COMPLEMENT ACTIVATION. C3 can be cleaved into COMPLEMENT C3A and COMPLEMENT C3B, spontaneously at low level or by C3 CONVERTASE at high level. The smaller fragment C3a is an ANAPHYLATOXIN and mediator of local inflammatory process. The larger fragment C3b binds with C3 convertase to form C5 convertase. C3 Complement,C3 Precursor,Complement 3,Complement C3 Precursor,Complement Component 3,Precursor-Complement 3,Pro-C3,Pro-Complement 3,C3 Precursor, Complement,C3, Complement,Complement, C3,Component 3, Complement,Precursor Complement 3,Precursor, C3,Precursor, Complement C3,Pro C3,Pro Complement 3
D003181 Complement C4 A glycoprotein that is important in the activation of CLASSICAL COMPLEMENT PATHWAY. C4 is cleaved by the activated COMPLEMENT C1S into COMPLEMENT C4A and COMPLEMENT C4B. C4 Complement,C4 Complement Component,Complement 4,Complement C4, Precursor,Complement Component 4,Pro-C4,Pro-complement 4,C4, Complement,Complement Component, C4,Complement, C4,Component 4, Complement,Component, C4 Complement,Pro C4,Pro complement 4
D003182 Complement C5 C5 plays a central role in both the classical and the alternative pathway of COMPLEMENT ACTIVATION. C5 is cleaved by C5 CONVERTASE into COMPLEMENT C5A and COMPLEMENT C5B. The smaller fragment C5a is an ANAPHYLATOXIN and mediator of inflammatory process. The major fragment C5b binds to the membrane initiating the spontaneous assembly of the late complement components, C5-C9, into the MEMBRANE ATTACK COMPLEX. C5 Complement,Complement 5,Complement C5, Precursor,Complement Component 5,Precursor C5,Pro-C5,Pro-complement 5,C5, Complement,C5, Precursor,C5, Precursor Complement,Complement, C5,Component 5, Complement,Precursor Complement C5,Pro C5,Pro complement 5
D003449 Cryoglobulinemia A condition characterized by the presence of abnormal quantities of CRYOGLOBULINS in the blood. Upon cold exposure, these abnormal proteins precipitate into the microvasculature leading to restricted blood flow in the exposed areas. Cryoglobulinemias
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

A Miadonna, and E Leggieri, and A Tedeschi, and M Cottini, and F Invernizzi, and M Froldi, and C Zanussi
January 1981, Acta haematologica,
A Miadonna, and E Leggieri, and A Tedeschi, and M Cottini, and F Invernizzi, and M Froldi, and C Zanussi
January 2012, Clinical & developmental immunology,
A Miadonna, and E Leggieri, and A Tedeschi, and M Cottini, and F Invernizzi, and M Froldi, and C Zanussi
January 1980, La Ricerca in clinica e in laboratorio,
A Miadonna, and E Leggieri, and A Tedeschi, and M Cottini, and F Invernizzi, and M Froldi, and C Zanussi
July 2021, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver,
A Miadonna, and E Leggieri, and A Tedeschi, and M Cottini, and F Invernizzi, and M Froldi, and C Zanussi
March 1976, Bollettino dell'Istituto sieroterapico milanese,
A Miadonna, and E Leggieri, and A Tedeschi, and M Cottini, and F Invernizzi, and M Froldi, and C Zanussi
October 1983, Clinical immunology and immunopathology,
A Miadonna, and E Leggieri, and A Tedeschi, and M Cottini, and F Invernizzi, and M Froldi, and C Zanussi
October 1980, La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris,
A Miadonna, and E Leggieri, and A Tedeschi, and M Cottini, and F Invernizzi, and M Froldi, and C Zanussi
September 1981, Medicina clinica,
A Miadonna, and E Leggieri, and A Tedeschi, and M Cottini, and F Invernizzi, and M Froldi, and C Zanussi
January 1985, Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia,
A Miadonna, and E Leggieri, and A Tedeschi, and M Cottini, and F Invernizzi, and M Froldi, and C Zanussi
October 1987, The American journal of medicine,
Copied contents to your clipboard!